Animal studies show promise for implantable heart pump
This article was originally published in Clinica
Early animal studies of a new-generation totally implantable left ventricular assist device (LVAD) have shown promising results. The pulsatile APEX LVAD combines a prototype blood pressure sensing and monitoring system which allows the LVAD pumping rate to be increased or decreased depending on any improvement or reduction of the patient's heart pumping capacity.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.